Seeds of Freedom, Manu Chao’s new song against Monsanto

Seeds of Freedom is the new song of French musician and singer-songwriter of Spanish origin Manu Chao, dedicated to the fight that farmers and peasants are carrying out against agrochemical giant Monsanto, and in support to the International Monstanto Tribunal. On 18 April the Monsanto Tribunal, an international civil society initiative to hold Monsanto accountable for

Seeds of Freedom is the new song of French musician and singer-songwriter of Spanish origin Manu Chao, dedicated to the fight that farmers and peasants are carrying out against agrochemical giant Monsanto, and in support to the International Monstanto Tribunal.

international monsanto tribunal
The International Monsanto Tribunal © Monsanto Tribunal/Facebook

On 18 April the Monsanto Tribunal, an international civil society initiative to hold Monsanto accountable for human and environmental rights violations, accused Monsanto of ecocide. In particular, the multinational is accused of threatening biodiversity, obstructing the right to food, increasing risks linked to food security and impinging farmers’ freedom.

Siamo anche su WhatsApp. Segui il canale ufficiale LifeGate per restare aggiornata, aggiornato sulle ultime notizie e sulle nostre attività.

Licenza Creative Commons
Quest'opera è distribuita con Licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 4.0 Internazionale.

Related articles
How agricultural chemicals are poisoning our world. And all the (false) myths about them

Corporations are putting our lives and our environment at risk through a growing and improper influence over institutions, whose responsibility should be, instead, protecting people and the planet. The visible consequences have made it imperative to expose their devious tactics and their steadfast and corrupt lobbying, recently revealed in the Poison Papers (a compilation of over

Bayer acquires Monsanto for 66 billion dollars

Monsanto has said yes. After 5 months of negotiations and hesitations, the US company has accepted Bayer’s offer of 66 billion dollars, debt included. So, the value of each share is now 128 dollars, up from Bayer’s previous offer of 127.50 dollars a share. In addition, the German pharmaceutical company has pledged to pay a